DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM

DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM was reported 2033 times

DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MEDICAL DEVICE SITE COLDNESS 1 0.5000
1 MEDICAL DEVICE SITE WARMTH 1 0.0213
2 PHARYNGO-OESOPHAGEAL DIVERTICULUM 1 0.0110
3 SEPTIC PULMONARY EMBOLISM 2 0.0103
4 EYELID RETRACTION 1 0.0100
5 EYELID MYOCLONUS 1 0.0100
6 PERINEAL RASH 1 0.0081
7 ANTI-THYROID ANTIBODY INCREASED 1 0.0079
8 HETEROPHORIA 1 0.0069
9 DRUG THERAPEUTIC INCOMPATIBILITY 1 0.0065
10 GRANULOCYTOSIS 1 0.0051
11 DEAFNESS PERMANENT 1 0.0051
12 SLEEP DISORDER THERAPY 1 0.0051
13 EXSANGUINATION 1 0.0050
14 SALIVARY GLAND PAIN 1 0.0046
15 SELF-INDUCED VOMITING 1 0.0046
16 VERY LOW DENSITY LIPOPROTEIN INCREASED 1 0.0045
17 CATHETER SITE RASH 2 0.0044
18 FEELING OF RELAXATION 3 0.0044
19 PRODUCT PACKAGE ASSOCIATED INJURY 9 0.0040
20 PRODUCT CLOSURE REMOVAL DIFFICULT 4 0.0039
21 INCORRECT DRUG ADMINISTRATION DURATION 101 0.0036
22 MEDICAL DEVICE MONITORING ERROR 1 0.0036
23 MEDICAL DEVICE SITE PAIN 2 0.0036
24 BURSA DISORDER 1 0.0034
25 LITHIASIS 1 0.0033
26 INAPPROPRIATE PRESCRIBING 2 0.0032
27 CONTRAINDICATED DEVICE USED 1 0.0031
28 CONJUNCTIVITIS BACTERIAL 1 0.0029
29 INCORRECT DOSAGE ADMINISTERED 14 0.0029
30 PRODUCT COMMINGLING 3 0.0028
31 ANGIODYSPLASIA 1 0.0027
32 ERYTHROMELALGIA 1 0.0027
33 SHOCK SYMPTOM 1 0.0027
34 HEARING DISABILITY 1 0.0026
35 HANGOVER 9 0.0026
36 PRODUCT LABEL ON WRONG PRODUCT 1 0.0025
37 PRODUCT USE ISSUE 466 0.0025
38 DELUSIONAL PERCEPTION 1 0.0024
39 MEDICATION ERROR 133 0.0024
40 SYSTOLIC HYPERTENSION 1 0.0023
41 THERAPEUTIC RESPONSE UNEXPECTED 103 0.0023
42 FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT 1 0.0023
43 CATHETER MANAGEMENT 2 0.0022
44 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0022
45 CLONUS 6 0.0022
46 COR PULMONALE 2 0.0021
47 PHARYNGEAL ABSCESS 1 0.0020
48 OESOPHAGEAL ULCER HAEMORRHAGE 1 0.0020
49 APPLICATION SITE INFECTION 1 0.0020
50 BREAST CONSERVING SURGERY 1 0.0020
51 INFECTIOUS COLITIS 1 0.0019
52 KETOSIS 2 0.0018
53 EXPIRED PRODUCT ADMINISTERED 61 0.0018
54 DRUG EFFECT PROLONGED 1 0.0018
55 BODY TINEA 1 0.0018
56 INITIAL INSOMNIA 18 0.0018
57 OESOPHAGEAL IRRITATION 1 0.0017
58 POOR QUALITY SLEEP 37 0.0017
59 THOUGHT BLOCKING 1 0.0017
60 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
61 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1 0.0017
62 MEAN PLATELET VOLUME INCREASED 1 0.0017
63 NEURODEGENERATIVE DISORDER 1 0.0016
64 LOWER EXTREMITY MASS 1 0.0016
65 HEPATOBILIARY DISEASE 1 0.0016
66 PRODUCT USED FOR UNKNOWN INDICATION 2 0.0016
67 FOREIGN BODY IN RESPIRATORY TRACT 2 0.0015
68 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
69 FOREIGN BODY 6 0.0015
70 INJECTION SITE MACULE 1 0.0015
71 PEPTIC ULCER HAEMORRHAGE 1 0.0014
72 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
73 PERINEAL PAIN 1 0.0014
74 RESTLESS LEGS SYNDROME 25 0.0014
75 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 1 0.0014
76 DRUG EFFECT DELAYED 6 0.0013
77 MONOCLONAL IMMUNOGLOBULIN PRESENT 1 0.0013
78 INCORRECT PRODUCT ADMINISTRATION DURATION 27 0.0012
79 GENITAL INFECTION FUNGAL 1 0.0012
80 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
81 MEDICATION OVERUSE HEADACHE 1 0.0012
82 ENDOCRINE OPHTHALMOPATHY 1 0.0012
83 OESOPHAGEAL OBSTRUCTION 1 0.0012
84 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
85 TRANSFUSION REACTION 1 0.0011
86 CEREBELLAR ATROPHY 1 0.0011
87 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 33 0.0011
88 BLOOD ALBUMIN INCREASED 1 0.0011
89 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
90 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 60 0.0011
91 GASTRIC ULCER HAEMORRHAGE 6 0.0011
92 PHARYNGEAL HYPOAESTHESIA 1 0.0011
93 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
94 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
95 PRODUCT LABEL ISSUE 7 0.0010
96 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
97 EXTRA DOSE ADMINISTERED 40 0.0010
98 BREAST DISCOMFORT 1 0.0010
99 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
100 BONE DEMINERALISATION 1 0.0009
101 FEELING JITTERY 18 0.0009
102 SMALL INTESTINAL STENOSIS 1 0.0009
103 DEVICE INEFFECTIVE 1 0.0009
104 PRODUCT NAME CONFUSION 1 0.0009
105 NAIL GROWTH ABNORMAL 1 0.0009
106 CHOKING SENSATION 5 0.0009
107 PRODUCT LOT NUMBER ISSUE 2 0.0009
108 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
109 DRUG EFFECT VARIABLE 1 0.0009
110 MORBID THOUGHTS 1 0.0009
111 BILE DUCT STENOSIS 1 0.0008
112 DYSFUNCTIONAL UTERINE BLEEDING 1 0.0008
113 OTITIS EXTERNA 1 0.0008
114 VICTIM OF CRIME 1 0.0008
115 UNDERDOSE 59 0.0008
116 LIP DISCOLOURATION 1 0.0008
117 CANCER PAIN 2 0.0008
118 POOR QUALITY DRUG ADMINISTERED 5 0.0008
119 DRUG EFFECT INCOMPLETE 28 0.0008
120 PRODUCT USE COMPLAINT 12 0.0008
121 ACROCHORDON 1 0.0008
122 MIDDLE INSOMNIA 14 0.0007
123 MIGRAINE WITH AURA 2 0.0007
124 CARBON DIOXIDE INCREASED 1 0.0007
125 FORMICATION 5 0.0007
126 INSOMNIA 185 0.0007
127 ENERGY INCREASED 4 0.0007
128 NEPHRECTOMY 1 0.0007
129 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
130 GASTROSTOMY 1 0.0006
131 PHARYNGEAL PARAESTHESIA 1 0.0006
132 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
133 SPLEEN DISORDER 1 0.0006
134 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 4 0.0006
135 BLADDER NEOPLASM 1 0.0006
136 PRODUCT COLOUR ISSUE 3 0.0006
137 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
138 SENSITIVITY OF TEETH 1 0.0006
139 WOUND INFECTION STAPHYLOCOCCAL 1 0.0006
140 INFUSION SITE DISCHARGE 1 0.0006
141 TERMINAL INSOMNIA 1 0.0006
142 BREAST CYST 1 0.0006
143 SOMNOLENCE 113 0.0006
144 PRODUCT PRESCRIBING ISSUE 12 0.0006
145 LYMPH NODE PAIN 1 0.0005
146 SEROTONIN SYNDROME 10 0.0005
147 MULTIPLE ALLERGIES 4 0.0005
148 OCCULT BLOOD POSITIVE 1 0.0005
149 ULCER 8 0.0005
150 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
151 LARGE INTESTINAL STENOSIS 1 0.0005
152 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
153 EYE CONTUSION 1 0.0005
154 ABNORMAL DREAMS 13 0.0005
155 NIGHTMARE 16 0.0005
156 PRODUCT USE IN UNAPPROVED INDICATION 113 0.0005
157 BLOOD CREATINE INCREASED 2 0.0005
158 GASTROINTESTINAL ULCER 1 0.0005
159 ULCER HAEMORRHAGE 3 0.0004
160 CHRONIC GASTRITIS 1 0.0004
161 ONYCHOCLASIS 3 0.0004
162 MENOPAUSAL SYMPTOMS 1 0.0004
163 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
164 VOLVULUS 1 0.0004
165 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
166 MYOCLONUS 5 0.0004
167 RADIUS FRACTURE 1 0.0004
168 WRONG DOSE 1 0.0004
169 RESTLESSNESS 15 0.0004
170 APPLICATION SITE BURN 2 0.0004
171 STAPHYLOCOCCAL SEPSIS 2 0.0004
172 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
173 SLUGGISHNESS 4 0.0004
174 INCREASED UPPER AIRWAY SECRETION 2 0.0004
175 BLOOD CHLORIDE DECREASED 1 0.0004
176 INTENTIONAL PRODUCT MISUSE 33 0.0004
177 MACULE 1 0.0004
178 DRUG INEFFECTIVE 461 0.0003
179 PRODUCT PHYSICAL ISSUE 7 0.0003
180 WRONG DRUG ADMINISTERED 3 0.0003
181 CREPITATIONS 1 0.0003
182 OROPHARYNGEAL DISCOMFORT 3 0.0003
183 EYE INJURY 1 0.0003
184 SELF INJURIOUS BEHAVIOUR 1 0.0003
185 MASTICATION DISORDER 1 0.0003
186 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
187 PRURITUS GENERALISED 7 0.0003
188 PRE-EXISTING CONDITION IMPROVED 2 0.0003
189 INCORRECT DOSE ADMINISTERED 73 0.0003
190 DRUG EFFECT INCREASED 1 0.0003
191 SCREAMING 2 0.0003
192 PNEUMONIA VIRAL 1 0.0003
193 NERVOUSNESS 16 0.0003
194 LISTLESS 1 0.0003
195 PEPTIC ULCER 1 0.0003
196 SKIN MASS 2 0.0003
197 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
198 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
199 RESPIRATION ABNORMAL 2 0.0003
200 MICTURITION DISORDER 1 0.0003
201 ORAL DISCOMFORT 4 0.0003
202 RIGHT VENTRICULAR FAILURE 2 0.0003
203 EAR PRURITUS 1 0.0003
204 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
205 FIBRIN D DIMER INCREASED 1 0.0003
206 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
207 RENAL DISORDER 13 0.0003
208 DISORIENTATION 11 0.0003
209 FAECES DISCOLOURED 6 0.0003
210 PARANASAL SINUS DISCOMFORT 1 0.0003
211 FACE INJURY 1 0.0003
212 TROPONIN INCREASED 2 0.0003
213 GASTRIC HAEMORRHAGE 3 0.0003
214 OESOPHAGEAL ULCER 1 0.0003
215 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
216 FAECES HARD 1 0.0003
217 EPIGASTRIC DISCOMFORT 1 0.0003
218 DRUG SCREEN POSITIVE 2 0.0003
219 OBSTRUCTION 1 0.0003
220 ENURESIS 1 0.0002
221 FEELING ABNORMAL 59 0.0002
222 TRIGGER FINGER 1 0.0002
223 APPLICATION SITE EXFOLIATION 1 0.0002
224 SENSATION OF FOREIGN BODY 2 0.0002
225 TONGUE DISCOMFORT 1 0.0002
226 ABSCESS LIMB 1 0.0002
227 MYDRIASIS 3 0.0002
228 PRODUCT CONTAINER ISSUE 2 0.0002
229 GASTRIC DISORDER 8 0.0002
230 ABNORMAL SENSATION IN EYE 1 0.0002
231 MUSCULOSKELETAL DISCOMFORT 4 0.0002
232 MELANOCYTIC NAEVUS 1 0.0002
233 PARONYCHIA 1 0.0002
234 HAEMORRHAGIC ANAEMIA 1 0.0002
235 LUNG INFILTRATION 2 0.0002
236 ABDOMINAL ABSCESS 1 0.0002
237 LIMB DISCOMFORT 7 0.0002
238 PHYSICAL DISABILITY 1 0.0002
239 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
240 THIRST 4 0.0002
241 QUALITY OF LIFE DECREASED 3 0.0002
242 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 45 0.0002
243 AGITATION 16 0.0002
244 INTERCEPTED MEDICATION ERROR 1 0.0002
245 GASTRITIS EROSIVE 1 0.0002
246 SQUAMOUS CELL CARCINOMA 2 0.0002
247 SKIN ABRASION 1 0.0002
248 PRODUCT PACKAGING ISSUE 2 0.0002
249 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
250 MEDICATION RESIDUE PRESENT 1 0.0002
251 HYPERSOMNIA 6 0.0002
252 DRUG PRESCRIBING ERROR 4 0.0002
253 HUMERUS FRACTURE 1 0.0002
254 PHARYNGEAL SWELLING 2 0.0002
255 PANCREATIC DISORDER 1 0.0002
256 ABDOMINAL PAIN UPPER 41 0.0002
257 VULVOVAGINAL PRURITUS 1 0.0002
258 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
259 DEVICE RELATED INFECTION 3 0.0002
260 MALABSORPTION 1 0.0002
261 PRODUCT ODOUR ABNORMAL 2 0.0002
262 TRANSFUSION 2 0.0002
263 SCRATCH 2 0.0002
264 RENAL PAIN 2 0.0002
265 INTENTIONAL OVERDOSE 12 0.0002
266 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
267 BRUXISM 1 0.0002
268 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
269 OESOPHAGITIS 2 0.0002
270 ASTHENOPIA 1 0.0002
271 HYPERKERATOSIS 1 0.0002
272 PROSTATIC DISORDER 1 0.0002
273 HEART RATE ABNORMAL 1 0.0002
274 CHROMATURIA 4 0.0002
275 ABNORMAL BEHAVIOUR 7 0.0002
276 MYOCARDIAL ISCHAEMIA 2 0.0002
277 INTERNAL HAEMORRHAGE 2 0.0002
278 ABDOMINAL DISCOMFORT 29 0.0002
279 RALES 1 0.0002
280 PRODUCT LABEL CONFUSION 1 0.0002
281 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
282 METASTASES TO LIVER 3 0.0002
283 HEAD DISCOMFORT 3 0.0002
284 HEARING IMPAIRED 1 0.0002
285 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
286 NOCTURIA 2 0.0002
287 TENSION 1 0.0002
288 VULVOVAGINAL BURNING SENSATION 1 0.0002
289 PIGMENTATION DISORDER 1 0.0002
290 SWELLING OF EYELID 1 0.0002
291 INFUSION SITE SWELLING 1 0.0002
292 FLATULENCE 9 0.0002
293 PHOTOPSIA 1 0.0002
294 GASTRIC ULCER 3 0.0002
295 ENTERITIS 1 0.0002
296 THROAT IRRITATION 7 0.0002
297 PROCTALGIA 1 0.0002
298 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
299 DYSPEPSIA 15 0.0002
300 SOMNAMBULISM 1 0.0002
301 HAEMATOCRIT DECREASED 3 0.0002
302 ADVERSE REACTION 2 0.0002
303 FEAR 4 0.0001
304 SUICIDE ATTEMPT 9 0.0001
305 SINUS CONGESTION 2 0.0001
306 THROAT TIGHTNESS 4 0.0001
307 HYPERHIDROSIS 19 0.0001
308 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
309 HAIR GROWTH ABNORMAL 1 0.0001
310 LARGE INTESTINE POLYP 1 0.0001
311 HAEMOPTYSIS 4 0.0001
312 PAPULE 1 0.0001
313 DUODENAL ULCER 1 0.0001
314 HAND FRACTURE 1 0.0001
315 DIALYSIS 2 0.0001
316 VISUAL FIELD DEFECT 1 0.0001
317 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
318 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
319 DYSGEUSIA 10 0.0001
320 FEELING DRUNK 1 0.0001
321 HYPOAESTHESIA ORAL 2 0.0001
322 BLOOD COUNT ABNORMAL 2 0.0001
323 TINNITUS 6 0.0001
324 PHARYNGEAL OEDEMA 2 0.0001
325 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
326 CONCUSSION 1 0.0001
327 PALPITATIONS 15 0.0001
328 SLEEP DISORDER 9 0.0001
329 HAEMATOCHEZIA 7 0.0001
330 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
331 OCULAR HYPERAEMIA 6 0.0001
332 FURUNCLE 1 0.0001
333 MUSCLE DISORDER 1 0.0001
334 ABNORMAL FAECES 1 0.0001
335 METASTASES TO BONE 2 0.0001
336 HICCUPS 1 0.0001
337 HEART RATE INCREASED 12 0.0001
338 EMBOLISM 1 0.0001
339 POLLAKIURIA 5 0.0001
340 VITAMIN D DECREASED 1 0.0001
341 BLOOD MAGNESIUM DECREASED 1 0.0001
342 MUSCLE STRAIN 1 0.0001
343 DISCOMFORT 7 0.0001
344 URINE OUTPUT DECREASED 1 0.0001
345 NAIL DISORDER 1 0.0001
346 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
347 GROIN PAIN 1 0.0001
348 FACIAL PAIN 1 0.0001
349 MYOSITIS 1 0.0001
350 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
351 DYSURIA 4 0.0001
352 OROPHARYNGEAL PAIN 10 0.0001
353 PRODUCT DISTRIBUTION ISSUE 1 0.0001
354 HEPATIC STEATOSIS 2 0.0001
355 THINKING ABNORMAL 2 0.0001
356 EPISTAXIS 8 0.0001
357 UNEVALUABLE EVENT 8 0.0001
358 BLOOD URINE PRESENT 2 0.0001
359 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
360 BLOOD PRESSURE INCREASED 16 0.0001
361 ACUTE RESPIRATORY FAILURE 2 0.0001
362 HEPATOMEGALY 1 0.0001
363 VITREOUS FLOATERS 1 0.0001
364 PARAESTHESIA 16 0.0001
365 KNEE OPERATION 1 0.0001
366 SINUS DISORDER 2 0.0001
367 SALIVARY HYPERSECRETION 1 0.0001
368 BURNING SENSATION 7 0.0001
369 BRAIN INJURY 1 0.0001
370 HYPOTHERMIA 1 0.0001
371 EYELID PTOSIS 1 0.0001
372 DRY THROAT 1 0.0001
373 DRUG ADMINISTRATION ERROR 3 0.0001
374 EAR DISCOMFORT 1 0.0001
375 MOBILITY DECREASED 7 0.0001
376 RIB FRACTURE 2 0.0001
377 NERVOUS SYSTEM DISORDER 3 0.0001
378 PULMONARY HYPERTENSION 2 0.0001
379 TENDERNESS 1 0.0001
380 PAIN IN EXTREMITY 28 0.0001
381 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
382 HEAD INJURY 3 0.0001
383 INCONTINENCE 1 0.0001
384 FULL BLOOD COUNT ABNORMAL 1 0.0001
385 MOOD SWINGS 3 0.0001
386 BODY HEIGHT DECREASED 1 0.0001
387 DECREASED ACTIVITY 1 0.0001
388 SKIN LACERATION 1 0.0001
389 BACK INJURY 1 0.0001
390 TOOTH FRACTURE 1 0.0001
391 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
392 DENTAL CARIES 1 0.0001
393 FOOT DEFORMITY 1 0.0001
394 NERVE INJURY 1 0.0001
395 BLISTER 5 0.0001
396 BLOOD CALCIUM DECREASED 1 0.0001
397 ANGER 3 0.0001
398 EYE INFECTION 1 0.0001
399 APPLICATION SITE PRURITUS 2 0.0001
400 IMPAIRED DRIVING ABILITY 1 0.0001
401 MICTURITION URGENCY 1 0.0001
402 MUSCLE SPASMS 16 0.0001
403 MUSCLE TWITCHING 2 0.0001
404 EYELID OEDEMA 1 0.0001
405 HYPERKALAEMIA 3 0.0001
406 SPLENOMEGALY 1 0.0001
407 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
408 WRIST FRACTURE 1 0.0001
409 VERTIGO 5 0.0001
410 MUSCLE SPASTICITY 1 0.0001
411 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
412 APPLICATION SITE IRRITATION 1 0.0001
413 DIZZINESS 40 0.0001
414 SECRETION DISCHARGE 1 0.0001
415 HOT FLUSH 6 0.0001
416 COLITIS 3 0.0001
417 HAEMATEMESIS 2 0.0001
418 PERIPHERAL SWELLING 12 0.0001
419 INFUSION SITE PAIN 1 0.0001
420 HIATUS HERNIA 1 0.0001
421 SWELLING FACE 5 0.0001
422 APPLICATION SITE ERYTHEMA 2 0.0001
423 ANHEDONIA 2 0.0001
424 INCORRECT PRODUCT STORAGE 1 0.0001
425 TOOTH INFECTION 1 0.0001
426 PRURITUS 29 0.0001
427 EYE HAEMORRHAGE 1 0.0001
428 DRUG EFFECT DECREASED 4 0.0001
429 DRY MOUTH 6 0.0001
430 PRODUCT TASTE ABNORMAL 1 0.0001
431 ANXIETY 21 0.0001
432 LIMB INJURY 2 0.0001
433 SKIN LESION 2 0.0001
434 PERIPHERAL COLDNESS 1 0.0001
435 TREMOR 12 0.0001
436 MENTAL STATUS CHANGES 2 0.0001
437 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
438 HEADACHE 45 0.0001
439 APHONIA 1 0.0001
440 MASS 1 0.0001
441 OXYGEN SATURATION DECREASED 4 0.0001
442 BLOOD TEST ABNORMAL 1 0.0001
443 SEASONAL ALLERGY 1 0.0001
444 RED BLOOD CELL COUNT DECREASED 2 0.0001
445 EYE IRRITATION 4 0.0001
446 FLUID OVERLOAD 1 0.0001
447 SKIN HAEMORRHAGE 1 0.0001
448 RENAL INJURY 2 0.0001
449 COLON CANCER 1 0.0001
450 ASTHENIA 25 0.0001
451 ECONOMIC PROBLEM 1 0.0001
452 OSTEOPENIA 1 0.0001
453 DEVICE FAILURE 1 0.0001
454 URTICARIA 11 0.0001
455 DRUG DISPENSING ERROR 1 0.0001
456 NEPHROLITHIASIS 3 0.0001
457 INSURANCE ISSUE 1 0.0001
458 THYROID DISORDER 1 0.0001
459 HYPERSENSITIVITY 12 0.0001
460 MUSCULOSKELETAL CHEST PAIN 1 0.0001
461 TENDONITIS 1 0.0001
462 BASAL CELL CARCINOMA 1 0.0001
463 PRODUCTIVE COUGH 3 0.0001
464 SCIATICA 1 0.0001
465 METABOLIC ACIDOSIS 2 0.0001
466 BLOOD GLUCOSE DECREASED 3 0.0001
467 LOSS OF CONSCIOUSNESS 8 0.0001
468 SENSORY DISTURBANCE 1 0.0001
469 MOVEMENT DISORDER 2 0.0001
470 DRUG DEPENDENCE 10 0.0001
471 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
472 NIGHT SWEATS 2 0.0001
473 CONFUSIONAL STATE 10 0.0001
474 MUSCLE TIGHTNESS 1 0.0001
475 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
476 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
477 HYPOAESTHESIA 9 0.0001
478 FALL 20 0.0001
479 CELLULITIS 3 0.0001
480 EYE PRURITUS 2 0.0001
481 HAEMOGLOBIN DECREASED 6 0.0001
482 SCAR 1 0.0001
483 HAEMATURIA 2 0.0001
484 ERYTHEMA 12 0.0001
485 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
486 PARANOIA 1 0.0001
487 FATIGUE 45 0.0001
488 GAIT DISTURBANCE 11 0.0001
489 RASH MACULAR 2 0.0001
490 DEVICE USE ISSUE 1 0.0001
491 HYPOXIA 2 0.0001
492 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
493 LYMPHOCYTE COUNT DECREASED 1 0.0001
494 GALLBLADDER DISORDER 1 0.0001
495 RASH PRURITIC 3 0.0001
496 LEUKOCYTOSIS 1 0.0001
497 TOOTHACHE 1 0.0001
498 BONE DISORDER 1 0.0001
499 ANAPHYLACTIC REACTION 3 0.0001
500 ADVERSE EVENT 5 0.0001
501 CHEST PAIN 10 0.0001
502 PHOTOPHOBIA 1 0.0001
503 DYSPNOEA EXERTIONAL 2 0.0001
504 HALLUCINATION 4 0.0001
505 NAUSEA 42 0.0001
506 DYSPHAGIA 5 0.0001
507 SLEEP APNOEA SYNDROME 1 0.0001
508 LETHARGY 3 0.0001
509 POST PROCEDURAL COMPLICATION 1 0.0001
510 LOWER LIMB FRACTURE 1 0.0001
511 CONTUSION 5 0.0001
512 HYPERTENSION 11 0.0001
513 ERUCTATION 1 0.0001
514 EAR PAIN 1 0.0001
515 OFF LABEL USE 45 0.0001
516 HAEMORRHOIDS 1 0.0001
517 CHOKING 1 0.0001
518 BONE PAIN 3 0.0001
519 VISION BLURRED 7 0.0001
520 WHEEZING 3 0.0001
521 DISABILITY 1 0.0001
522 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
523 UPPER LIMB FRACTURE 1 0.0001
524 DIARRHOEA 32 0.0000
525 INTENTIONAL SELF-INJURY 1 0.0000
526 PLEURAL EFFUSION 3 0.0000
527 TASTE DISORDER 1 0.0000
528 OEDEMA PERIPHERAL 6 0.0000
529 DYSKINESIA 2 0.0000
530 BONE MARROW FAILURE 1 0.0000
531 FEELING HOT 3 0.0000
532 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
533 HAEMORRHAGE 5 0.0000
534 BACK PAIN 11 0.0000
535 ANAEMIA 9 0.0000
536 JOINT INJURY 1 0.0000
537 RECTAL HAEMORRHAGE 2 0.0000
538 SKIN CANCER 1 0.0000
539 RHINORRHOEA 3 0.0000
540 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
541 MENTAL DISORDER 2 0.0000
542 PRODUCT DOSE OMISSION 3 0.0000
543 MUSCULOSKELETAL STIFFNESS 4 0.0000
544 MELAENA 1 0.0000
545 RENAL FAILURE 6 0.0000
546 RASH PAPULAR 1 0.0000
547 PANCREATITIS ACUTE 1 0.0000
548 RHEUMATOID ARTHRITIS 5 0.0000
549 HEPATIC ENZYME INCREASED 3 0.0000
550 SUICIDAL IDEATION 4 0.0000
551 MEMORY IMPAIRMENT 6 0.0000
552 SKIN DISCOLOURATION 2 0.0000
553 SHOCK 1 0.0000
554 MALAISE 19 0.0000
555 VOMITING 20 0.0000
556 PULMONARY EMBOLISM 4 0.0000
557 NEUROPATHY PERIPHERAL 4 0.0000
558 PRODUCT PRESCRIBING ERROR 1 0.0000
559 MULTIPLE SCLEROSIS 2 0.0000
560 LOCALISED INFECTION 1 0.0000
561 EMOTIONAL DISTRESS 5 0.0000
562 CONSTIPATION 9 0.0000
563 MENTAL IMPAIRMENT 1 0.0000
564 PRESYNCOPE 1 0.0000
565 LIVER INJURY 1 0.0000
566 AGEUSIA 1 0.0000
567 SYNCOPE 4 0.0000
568 AGGRESSION 2 0.0000
569 FLUID RETENTION 2 0.0000
570 PAIN 24 0.0000
571 CHEST DISCOMFORT 4 0.0000
572 SINUSITIS 4 0.0000
573 DRUG RESISTANCE 1 0.0000
574 DYSPNOEA 22 0.0000
575 SEDATION 1 0.0000
576 JOINT STIFFNESS 1 0.0000
577 GASTRITIS 1 0.0000
578 DEPRESSED MOOD 2 0.0000
579 EAR INFECTION 1 0.0000
580 PLATELET COUNT DECREASED 4 0.0000
581 OVERDOSE 8 0.0000
582 FREQUENT BOWEL MOVEMENTS 1 0.0000
583 BLOOD BILIRUBIN INCREASED 1 0.0000
584 OEDEMA 2 0.0000
585 DIVERTICULITIS 1 0.0000
586 NECK PAIN 2 0.0000
587 HYPONATRAEMIA 2 0.0000
588 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
589 MUSCULAR WEAKNESS 4 0.0000
590 ANGINA PECTORIS 1 0.0000
591 HERPES ZOSTER 2 0.0000
592 PRODUCT SUBSTITUTION ISSUE 2 0.0000
593 BALANCE DISORDER 3 0.0000
594 DECREASED APPETITE 8 0.0000
595 NASAL CONGESTION 2 0.0000
596 LABORATORY TEST ABNORMAL 1 0.0000
597 URINARY INCONTINENCE 1 0.0000
598 CATARACT 2 0.0000
599 ADVERSE DRUG REACTION 3 0.0000
600 IRRITABILITY 2 0.0000
601 BLOOD POTASSIUM DECREASED 1 0.0000
602 HEPATIC FAILURE 1 0.0000
603 LACRIMATION INCREASED 1 0.0000
604 STOMATITIS 2 0.0000
605 EMOTIONAL DISORDER 1 0.0000
606 RASH 14 0.0000
607 SWELLING 3 0.0000
608 SWOLLEN TONGUE 1 0.0000
609 MIGRAINE 3 0.0000
610 CYSTITIS 1 0.0000
611 HYPOTHYROIDISM 1 0.0000
612 ARTHRALGIA 13 0.0000
613 WEIGHT INCREASED 7 0.0000
614 DEPRESSION 7 0.0000
615 BLOOD CREATININE INCREASED 2 0.0000
616 ALOPECIA 6 0.0000
617 OSTEONECROSIS 1 0.0000
618 DEHYDRATION 4 0.0000
619 SKIN DISORDER 1 0.0000
620 NEOPLASM MALIGNANT 2 0.0000
621 HYPOTENSION 6 0.0000
622 CONDITION AGGRAVATED 9 0.0000
623 URINARY TRACT INFECTION 5 0.0000
624 ILLNESS 3 0.0000
625 DEVICE USE ERROR 1 0.0000
626 NEOPLASM PROGRESSION 1 0.0000
627 WEIGHT DECREASED 8 0.0000
628 HEART RATE DECREASED 1 0.0000
629 INJURY 2 0.0000
630 PANIC ATTACK 1 0.0000
631 NASOPHARYNGITIS 5 0.0000
632 INJECTION SITE MASS 1 0.0000
633 BRONCHITIS 2 0.0000
634 EYE SWELLING 1 0.0000
635 ASTHMA 3 0.0000
636 INTESTINAL OBSTRUCTION 1 0.0000
637 CHRONIC KIDNEY DISEASE 2 0.0000
638 DIABETES MELLITUS 2 0.0000
639 ACUTE KIDNEY INJURY 4 0.0000
640 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
641 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
642 CHILLS 3 0.0000
643 DISEASE PROGRESSION 3 0.0000
644 DRUG INTERACTION 4 0.0000
645 CARDIAC FAILURE CONGESTIVE 2 0.0000
646 BLINDNESS 1 0.0000
647 LUNG NEOPLASM MALIGNANT 1 0.0000
648 OSTEOPOROSIS 1 0.0000
649 DRUG ABUSE 2 0.0000
650 RHABDOMYOLYSIS 1 0.0000
651 ROAD TRAFFIC ACCIDENT 1 0.0000
652 WITHDRAWAL SYNDROME 1 0.0000
653 RENAL IMPAIRMENT 2 0.0000
654 OSTEOARTHRITIS 1 0.0000
655 HYPOACUSIS 1 0.0000
656 PSORIASIS 3 0.0000
657 MYOCARDIAL INFARCTION 4 0.0000
658 ANGIOEDEMA 1 0.0000
659 LIVER DISORDER 1 0.0000
660 TACHYCARDIA 2 0.0000
661 COLITIS ULCERATIVE 1 0.0000
662 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
663 THERAPY NON-RESPONDER 1 0.0000
664 PRODUCT QUALITY ISSUE 3 0.0000
665 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
666 ABDOMINAL PAIN 5 0.0000
667 BLOOD CHOLESTEROL INCREASED 1 0.0000
668 COUGH 6 0.0000
669 CARDIAC DISORDER 2 0.0000
670 BLOOD GLUCOSE INCREASED 4 0.0000
671 ARRHYTHMIA 1 0.0000
672 RASH ERYTHEMATOUS 1 0.0000
673 DRUG INTOLERANCE 2 0.0000
674 LUNG DISORDER 1 0.0000
675 INFLAMMATION 1 0.0000
676 MUSCULOSKELETAL PAIN 1 0.0000
677 SPEECH DISORDER 1 0.0000
678 DISTURBANCE IN ATTENTION 1 0.0000
679 THROMBOCYTOPENIA 2 0.0000
680 EYE PAIN 1 0.0000
681 DYSPHONIA 1 0.0000
682 SURGERY 1 0.0000
683 BLADDER CANCER 1 0.0000
684 VISUAL IMPAIRMENT 2 0.0000
685 PNEUMONIA 5 0.0000
686 DEEP VEIN THROMBOSIS 1 0.0000
687 AMNESIA 1 0.0000
688 INFUSION RELATED REACTION 1 0.0000
689 BLOOD PRESSURE DECREASED 1 0.0000
690 THERAPY INTERRUPTED 1 0.0000
691 ARTHRITIS 1 0.0000
692 THROMBOSIS 1 0.0000
693 CARDIAC ARREST 1 0.0000
694 DRUG DOSE OMISSION 2 0.0000
695 TOXICITY TO VARIOUS AGENTS 2 0.0000
696 MYALGIA 2 0.0000
697 DRUG WITHDRAWAL SYNDROME 1 0.0000
698 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
699 GASTROINTESTINAL DISORDER 1 0.0000
700 NO ADVERSE EVENT 2 0.0000
701 BREAST CANCER 1 0.0000
702 ATRIAL FIBRILLATION 1 0.0000
703 FLUSHING 1 0.0000
704 ABDOMINAL DISTENSION 1 0.0000
705 DEATH 8 0.0000
706 INFLUENZA 1 0.0000
707 SEIZURE 1 0.0000
708 JOINT SWELLING 1 0.0000
709 DRY SKIN 1 0.0000
710 INFECTION 1 0.0000
711 PRODUCT DOSE OMISSION ISSUE 2 0.0000
712 INJECTION SITE PAIN 2 0.0000
713 HOSPITALISATION 1 0.0000
714 PYREXIA 2 0.0000
715 COVID-19 1 0.0000